Related Experiment Video
Updated: Mar 6, 2026
Nucleofection of Rodent Neuroblasts to Study Neuroblast Migration In vitro
Published on: November 12, 2013
ARID1A gene knockdown promotes neuroblastoma migration and invasion
Abstract:
Neuroblastoma is the most common extracranial solid tumor in childhood which often acquires drug resistance and becomes aggressive phenotypes. The high-risk patients suffer from high mortality due to the limitation of the treatment strategies. ARID1A (AT-rich interactive domain-containing protein 1A), a subunit of SWI/SNF complexes, is considered as a tumor suppressor in many cancers. The aim of the present study was to investigate the effect of ARID1A on migration and invasion in neuroblastoma cells. The shRNA targeting ARID1A was designed and delivered into SK-N-SH cells to knock down ARID1A expression. Knockdown of ARID1A by shRNA significantly increased the viability and invasion ability, and caused G1 arrest inhibition and DNA synthesis increase in SK-N-SH cells. Moreover, Knockdown of ARID1A increased the activity and expression of matrix metalloproteinase (MMP)-2 and -9 in SK-N-SH cells. Furthermore, ARID1A knockdown caused diminished expression of E-cadherin, enhanced expression of N-cadherin and β-catenin nuclear translocation in SK-N-SH cells. These results suggest that loss of ARID1A may associate with the promotion of invasion and metastasis of neuroblastoma. Our findings indicate ARID1A is a tumor suppressor in neuroblastoma.
Insights
Loss of ARID1A (AT-rich interactive domain-containing protein 1A) promotes neuroblastoma cell invasion and metastasis. This suggests ARID1A acts as a tumor suppressor, offering potential new therapeutic targets for aggressive neuroblastoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Neuroblastoma is a common childhood cancer with limited treatment options, often developing drug resistance and aggressive traits.
- High-risk neuroblastoma patients face poor prognoses due to treatment limitations.
- ARID1A (AT-rich interactive domain-containing protein 1A), a SWI/SNF complex subunit, functions as a tumor suppressor in various cancers.
Purpose of the Study:
- To investigate the role of ARID1A in regulating migration and invasion in neuroblastoma cells.
- To determine the impact of ARID1A knockdown on neuroblastoma cell behavior and molecular pathways.
Main Methods:
- ARID1A expression was knocked down in SK-N-SH neuroblastoma cells using shRNA.
- Cell viability, invasion, cell cycle progression, and DNA synthesis were assessed.
- Expression and activity of matrix metalloproteinase (MMP)-2 and -9 were analyzed.
- Changes in E-cadherin, N-cadherin, and β-catenin localization were evaluated.
Main Results:
- ARID1A knockdown significantly increased neuroblastoma cell viability and invasion.
- Knockdown led to G1 arrest inhibition and increased DNA synthesis.
- Matrix metalloproteinase (MMP)-2 and -9 activity and expression were elevated post-ARID1A knockdown.
- ARID1A loss diminished E-cadherin, enhanced N-cadherin, and promoted β-catenin nuclear translocation, indicative of epithelial-mesenchymal transition.
Conclusions:
- Loss of ARID1A is associated with enhanced invasion and metastasis in neuroblastoma.
- ARID1A functions as a tumor suppressor in neuroblastoma.
- Targeting ARID1A may offer a novel therapeutic strategy for aggressive neuroblastoma.
Related Concept Videos
01:35Cancer Cell Migration through Invadopodia
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...